Rubra Medicaments Peer Comparison
BSE: 531099
₹36.51
As on 28-Aug-2026 12:58IST
Market cap
₹20 Cr
Revenue (TTM)
₹562 Cr
P/E Ratio
16
P/B Ratio
10.5
Div. Yield
0 %
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
20 | 7,843 | 33 | 20 | 19 |
Revenue (₹ Cr) |
562 | 7,128 | 13 | -3 | 32 |
Net Profit (₹ Cr) |
1.24 | 167.66 | -1.78 | -0.07 | 0.84 |
Net Margin (%) |
0.22 | 2.35 | -8.71 | 2.62 | 2.62 |
RoE (%) |
9.81 | 7.58 | -1.56 | -0.66 | 17.29 |
Price to Earnings |
16.00 | 62.54 | -- | -- | 23.10 |
Price-To-Book |
10.49 | 4.52 | 0.30 | 2.02 | 4.04 |
Income Statement (₹ Cr)
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Operating Revenue
|
562.10 | 7,127.89 | 12.55 | -2.97 | 31.23 |
|
Total Income
|
562.10 | 7,144.31 | 20.47 | -2.52 | 31.64 |
|
Total Expenditure
|
560.08 | 6,815.02 | 20.42 | -2.46 | 28.78 |
|
EBITDA
|
2.02 | 312.87 | -7.87 | -0.52 | 2.45 |
|
Depreciation
|
0.01 | 46.73 | 1.82 | 0.00 | 0.08 |
|
EBIT
|
2.01 | 266.14 | -9.69 | -0.52 | 2.37 |
|
Interest
|
0.00 | 64.29 | 0.00 | 0.00 | 0.57 |
|
Other Income
|
0.00 | 16.42 | 7.92 | 0.45 | 0.41 |
|
Exceptional Items
|
0.00 | -8.18 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
2.01 | 210.09 | -1.77 | -0.07 | 2.22 |
|
Provision for Tax
|
0.77 | 42.43 | 0.02 | 0.00 | 0.08 |
|
Profit after Tax
|
1.24 | 167.66 | -1.78 | -0.07 | 2.13 |
Liabilities (₹ Cr)
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
23.23 | 1,688.61 | 111.61 | 9.70 | 6.47 |
|
Minority Interest
|
0.00 | -42.25 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
0.00 | 260.15 | 1.14 | -0.01 | 2.33 |
|
Current Liabilities
|
319.67 | 1,587.57 | 2.71 | -0.25 | 6.47 |
|
Total Liabilities
|
0.65 | 2,702.52 | 125.42 | 9.79 | -- |
Assets (₹ Cr)
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.02 | 917.21 | 67.70 | 1.27 | 7.85 |
|
Current Assets
|
342.89 | 2,508.44 | 47.02 | 7.93 | 7.35 |
|
Total Assets
|
0.65 | 2,702.52 | 125.42 | 9.79 | -- |
|
Total Debt*
|
0.00 | 298.81 | 0.00 | 0.00 | -- |
|
Net Current Assets
|
23.21 | 920.87 | 44.31 | 8.18 | 0.89 |
|
Contingent Liabilities
|
-- | 4.01 | -- | 1.72 | -- |
Cashflow (₹ Cr)
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
0.19 | -76.87 | 5.07 | 0.22 | -- |
|
Cash Flow from Investing Activities
|
-0.18 | 219.80 | -4.98 | -0.20 | -- |
|
Cash from Financing Activities
|
-- | -73.66 | -- | 0.00 | -- |
|
Net Cash Inflow / Outflow
|
0.01 | 69.27 | 0.09 | 0.01 | -- |
Ratios
Profitability Ratios
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
ROCE (%)
|
9.64 | 9.16 | -0.66 | 2.66 | -- |
|
ROE (%)
|
9.81 | 7.58 | -1.56 | -0.66 | 36.23 |
|
ROA (%)
|
0.72 | 5.32 | -1.48 | -0.69 | 13.45 |
|
EBIT Margin (%)
|
0.36 | 3.73 | -77.24 | 17.33 | 7.60 |
|
Net Margin (%)
|
0.22 | 2.35 | -8.71 | 2.62 | 6.74 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 29.75 | 0.00 |
Growth Ratios
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
4,540.45 | 31.94 | -42.88 | -150.48 | 15.29 |
|
EBIT Growth (%)
|
1,710.81 | 67.92 | -45.53 | -266.67 | 102.30 |
|
Net Profit Growth (%)
|
1,288.76 | 43.13 | 49.20 | -109.68 | 493.54 |
|
EPS Growth (%)
|
1,322.31 | 27.72 | 49.20 | -109.68 | 132.45 |
|
Book Value Growth (%)
|
4.77 | 5.11 | 0.24 | 2.10 | -- |
Valuation Ratios
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Price / Earnings
|
16.82 | 58.32 | -17.58 | -310.40 | 8.94 |
|
Price / Book Value
|
11.03 | 4.41 | 0.29 | 2.07 | 2.86 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
10.30 | 25.30 | -0.28 | -30.28 | 10.41 |
|
Market Cap (₹ Cr)
|
6.99 | 4,944.94 | 51.76 | 19.85 | -- |
Solvency Ratios
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.07 | 0.00 | 0.00 | 0.35 |
|
Short term debt to equity ratio
|
-- | 0.17 | -- | -- | -- |
|
Current Ratio
|
1.07 | 1.58 | 17.35 | -31.58 | 1.14 |
|
Quick Ratio
|
1.07 | 1.05 | 16.26 | -30.28 | 0.50 |
|
Interest Coverage
|
10.12 | 4.27 | -16.63 | -65.00 | 4.91 |
Operating Efficiency Ratios
| Rubra Medicaments | Entero Health | Medi-Caps | Pentokey Organy | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
60.08 | 17.01 | 55.16 | -39.13 | 7.99 |
|
Asset Turnover
|
3.27 | 2.26 | 0.10 | -0.31 | 1.97 |
|
Receivable days
|
362.19 | 51.78 | 140.45 | 482.34 | -- |
|
Inventory Days
|
0.00 | 38.71 | 64.01 | 144.64 | -- |
|
Payable days
|
-- | 24.83 | 63.40 | 44.32 | -- |
|
Cash Conversion Cycle
|
-- | 65.66 | 141.06 | 582.66 | -- |